Fierce Biotech November 14, 2022
Enrolling clinical trials quickly can make a big difference in cutting the time it takes for patients to access new therapies and enabling sponsors to leapfrog rivals in the race to market. But while the industry has yet to address a fundamental barrier to enrollment—low patient knowledge of clinical trials—the good news is that patients are interested in learning more.
Patients want more information about clinical trials, and biopharma now has the tools to reach them, new data from Phreesia Life Sciences suggests. A Phreesia survey of more than 4,000 people found that more than two-thirds (68%) of surveyed patients said they were interested in learning more about trials.
Only a tiny fraction of patients currently participate in clinical trials,...
Today's Sponsors
Today's Sponsor